Targeting the Tumor Ecosystem to address cancer drug resistance.
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States
What they do:
Breakthrough medicines unlocking the biology of heme
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Our drugs engage the immune system to fight tumors
Quick facts:
HQ: Salt Lake City, UT, United States
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Altay develops disease-modifying therapies targeting transcription…
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$15.7M · Equity · Oct 2026
What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States
Targeting the Tumor Ecosystem to address cancer drug resistance.
San Francisco, CA, United States
2 employees, according to the company profile.
There are no funding rounds for Alixia in our data.
Similar startups: Adventris Pharmaceuticals, Velorum Therapeutics, and Eris Biotech.